[go: up one dir, main page]

UA118192C2 - Противірусна фармацевтична композиція - Google Patents

Противірусна фармацевтична композиція

Info

Publication number
UA118192C2
UA118192C2 UAA201510327A UAA201510327A UA118192C2 UA 118192 C2 UA118192 C2 UA 118192C2 UA A201510327 A UAA201510327 A UA A201510327A UA A201510327 A UAA201510327 A UA A201510327A UA 118192 C2 UA118192 C2 UA 118192C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
glucan
beta
virus pharmaceutical
antiviral pharmaceutical
Prior art date
Application number
UAA201510327A
Other languages
English (en)
Russian (ru)
Inventor
Юрій Захарович Толчеєв
Вадим Олексійович Козловський
Original Assignee
Юрій Захарович Толчеєв
Вадим Олексійович Козловський
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юрій Захарович Толчеєв, Вадим Олексійович Козловський filed Critical Юрій Захарович Толчеєв
Priority to UAA201510327A priority Critical patent/UA118192C2/uk
Priority to RU2017125688A priority patent/RU2701514C2/ru
Priority to PCT/UA2016/000122 priority patent/WO2017069721A1/en
Priority to EA201800266A priority patent/EA036809B1/ru
Publication of UA118192C2 publication Critical patent/UA118192C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

У винаході розкривається противірусна фармацевтична композиція, яка містить бета-глюкан, переважно у вигляді карбоксиметил бета-глюкану натрієвої солі і йота-карагенану у ваговому співвідношенні від приблизно 1 до 0,5 до приблизно 1 до 5. Противірусна фармацевтична композиція може бути представлена у вигляді аерозолю для доставки за допомогою дозуючого інгалятора у вигляді назального або вагінального спрею, у вигляді порошку для інсуфляцій в порожнини тіла або в вигляді гелю.
UAA201510327A 2015-10-22 2015-10-22 Противірусна фармацевтична композиція UA118192C2 (uk)

Priority Applications (4)

Application Number Priority Date Filing Date Title
UAA201510327A UA118192C2 (uk) 2015-10-22 2015-10-22 Противірусна фармацевтична композиція
RU2017125688A RU2701514C2 (ru) 2015-10-22 2016-10-24 Антивирусная фармацевтическая композиция
PCT/UA2016/000122 WO2017069721A1 (en) 2015-10-22 2016-10-24 Antiviral pharmaceutical composition
EA201800266A EA036809B1 (ru) 2015-10-22 2016-10-24 Антивирусная фармацевтическая композиция

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201510327A UA118192C2 (uk) 2015-10-22 2015-10-22 Противірусна фармацевтична композиція

Publications (1)

Publication Number Publication Date
UA118192C2 true UA118192C2 (uk) 2018-12-10

Family

ID=64604286

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201510327A UA118192C2 (uk) 2015-10-22 2015-10-22 Противірусна фармацевтична композиція

Country Status (4)

Country Link
EA (1) EA036809B1 (uk)
RU (1) RU2701514C2 (uk)
UA (1) UA118192C2 (uk)
WO (1) WO2017069721A1 (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018222581A1 (en) * 2017-05-29 2018-12-06 Resinnate Therapeutics Llc Methods and formulations for administering beta glucan
CA3061438A1 (en) * 2017-06-07 2018-12-13 Societe Des Produits Nestle S.A. Powdered thickener maintaining its extensional properties when reconstituted and for promoting safe swallowing by individuals with dysphagia
FI3773501T3 (fi) 2018-03-29 2023-12-19 The Materia Company Ltd Emättimensisäinen valmiste
SE546142C2 (en) * 2020-04-03 2024-06-11 Liw Innovation Ab New compositions for oral use
GB202109888D0 (en) 2021-07-08 2021-08-25 Pollinner Ltd Nasal spray

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1273576A (en) 1987-09-16 1990-09-04 Patrick A. Beauchamp Topical treatment for diseased skin disorders
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
ITMI20032067A1 (it) 2003-10-23 2005-04-24 Unihart Corp Formulazione spray per il trattamento delle infezioni virali.
US20060165623A1 (en) * 2005-01-24 2006-07-27 Terra Firma Natuals, Inc. Natural deodorant composition
AU2007327934B2 (en) * 2006-12-05 2013-04-18 Marinomed Biotechnologie Gmbh Use of carrageenan for treating rhinovirus infections
US20080131454A1 (en) * 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
IT1393272B1 (it) 2009-02-20 2012-04-12 D M G Italia S R L Composizione farmaceutica contenente argento microcolloidale e carbossimetilbetaglucano per la disinfezione delle mucose nasali e suo procedimento di preparazione

Also Published As

Publication number Publication date
RU2017125688A3 (uk) 2019-01-23
EA036809B1 (ru) 2020-12-23
RU2701514C2 (ru) 2019-09-27
RU2017125688A (ru) 2019-01-23
WO2017069721A1 (en) 2017-04-27
EA201800266A1 (ru) 2018-09-28

Similar Documents

Publication Publication Date Title
CY1120605T1 (el) Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
MY161773A (en) Amylin analogues and pharmaceutical compositions thereof
PH12016500433A1 (en) Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
BR112016022598A8 (pt) composição aerossol farmacêutica na forma de um pó seco para liberação pulmonar, forma de dosagem unitária, pacote farmacêutico, kit e uso
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
UA118192C2 (uk) Противірусна фармацевтична композиція
PH12020551709A1 (en) Antiviral immunotropic agent for the treatment of acute respiratory viral infections
EA201291306A1 (ru) Состав сухого порошка, содержащий антимускариновое средство
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
MY175781A (en) Composition comprising at least two dry powders obtained by spray drying to increase the stability of the formulation
WO2016044839A3 (en) Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
WO2014007772A3 (en) Inhalation compositions comprising glucose anhydrous
ZA202007890B (en) Stable pharmaceutical compositions for pressurized metered dose inhalers
WO2014007770A3 (en) Inhalation compositions comprising corticosteroid and sorbitol
MY191712A (en) Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
WO2014007781A3 (en) Inhalation compositions
MX2017013950A (es) Polvos de zolmitriptán para suministro pulmonar.
EA202091618A1 (ru) Композиция кетамина в виде сухого порошка для применения при лечении депрессии ингаляционным путем
MX2015015150A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
EA201591415A1 (ru) Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
JOP20210075A1 (ar) مشتقات 4-بيرازين-2-يل ميثيل-مورفولين واستخدامها كدواء